Ultimately, the mutation is associated with impaired glucose tolerance and a reduction in glucose-stimulated insulin secretion in C57BL/6J mice15, which contributes to reported differences in the GTT profiles of the sub-strains15–18. The gene discussed is INS; the disease is Impaired glucose tolerance.